February 05, 2026 a 01:00 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. presents a compelling opportunity with its robust line of minimally invasive surgical systems. The company's innovative approach to integrating digital capabilities enhances hospital performance and offers significant value. Despite a highly competitive medical technology market, the consistent demand for advanced surgical solutions positions ISRG as a strong contender for long-term growth.
Historical Stock Grades
ISRG has shown a relatively stable pattern in analyst recommendations over the past months. As of February 2026, the majority sentiment is leaning toward a 'Buy', with notable support for 'Strong Buy'.
| Rating | Count | Score Bar |
|---|---|---|
| Strong Buy | 8 | |
| Buy | 16 | |
| Hold | 10 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
Recently, the overall analyst sentiment for ISRG has remained modestly bullish. However, subtle trends are evident:
- The proportion of 'Buy' ratings has held steady, indicating confidence in the company's performance.
- Hold ratings have seen minor fluctuations, reflecting mixed expectations about the stock's short-term movements.
- Sell recommendations remain minimal, underscoring a generally positive market outlook.
Percentage Trends
The percentage distribution of analyst ratings provides insight into market sentiment trends:
- 'Strong Buy' ratings exhibit a slight decrease over the year, moving from 10 to 8 recent positions.
- 'Buy' ratings have consistently constituted the majority, now making up 60% of the latest analytics.
- 'Hold' positions showed minor growth, indicating cautious investor perspectives amidst market volatility.
Latest Analyst Recommendations
Here are the latest recommendations from analysts, showing a balanced mix of actions:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-27 | Buy | Hold | Freedom Capital Markets |
| 2026-01-26 | Overweight | Overweight | Barclays |
| 2026-01-23 | Buy | Buy | BTIG |
| 2026-01-23 | Outperform | Outperform | Bernstein |
| 2026-01-23 | Neutral | Neutral | Citigroup |
Analyst Recommendations with Change of Opinion
Recent changes in analyst opinions reflect a dynamic evaluation of ISRG's market standing:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-27 | Buy | Hold | Freedom Capital Markets |
| 2025-12-11 | Neutral | Buy | Citigroup |
| 2025-06-09 | Sell | Hold | Deutsche Bank |
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
| 2024-11-19 | Buy | Hold | Erste Group |
Interpretation
Analyzing the data reveals a market sentiment that remains largely positive towards ISRG. With strong consistent 'Buy' and 'Strong Buy' ratings, there is underlying confidence in the company's growth trajectory. The subtle increase in 'Hold' ratings suggests some caution, potentially due to market volatility or competitive pressures. Overall, the ongoing upgrade activities indicate an optimistic outlook.
Conclusion
Intuitive Surgical, Inc. continues to hold a strong position in the minimally invasive surgery sector, backed by solid analyst recommendations. While there is a slight cooling in 'Strong Buy' ratings, the consistent 'Buy' support suggests sustained confidence. With an innovative product line and expanding market presence, ISRG may offer investors an attractive growth opportunity, tempered by typical sector risks such as regulatory and market competition.